Patents Assigned to Indiana State University
-
Publication number: 20190021695Abstract: Disclosed is an imaging transducer holding device for use with a patient that includes a holding structure which holds an imaging transducer and an attachment portion which attaches the holding structure to a patient. The holding device is useful for assessing the condition of a patient's blood vessel via ultrasound imaging. Also disclosed are a system and a method for imaging the vascular condition of a patient, the system containing the holding device and an imaging transducer.Type: ApplicationFiled: July 20, 2018Publication date: January 24, 2019Applicant: Indiana State UniversityInventors: Amy K. Watts, Francisco J. Morales, Alvaro N. Gurovich, Joseph O. West
-
Publication number: 20180179220Abstract: The invention provides novel nicotinic acetylcholine receptor agonists, for example, phantasmidine and derivatives thereof, for example a compound of formula I. Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acetylcholine receptor agonists.Type: ApplicationFiled: February 26, 2018Publication date: June 28, 2018Applicants: Indiana State University, The United States of America,as Represented by the Secretary, Department of Health and Human ServiceInventors: Richard W. Fitch, Thomas F. Spande, H. Martin Garraffo, Herman J.C. Yeh, John W. Daly (Deceased)
-
Patent number: 9902734Abstract: The invention provides novel nicotinic acetylcholine receptor agonists, for example, phantasmidine and derivatives thereof, for example a compound of formula I. Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acetylcholine receptor agonists.Type: GrantFiled: April 24, 2015Date of Patent: February 27, 2018Assignees: Indiana State University, The United States of America, as Represented by the Secretary, Department of Health and Human ServicesInventors: Richard W. Fitch, Thomas F. Spande, H. Martin Garraffo, Herman J. C. Yeh, John W. Daly
-
Patent number: 9757350Abstract: Replication protein A (RPA) is a single-strand DNA-binding protein with essential roles in DNA replication, recombination and repair. Small molecule inhibitors (SMIs) with the ability to disrupt RPA binding activity to ssDNA have been identified and assessed using both lung and ovarian cancer cell lines. Lung cancer cell lines demonstrated increased apoptotic cell death following treatment with the SMI MCI13E, with IC50 values of ˜5 ?M. The A2780 ovarian cancer cell line and the p53-null lung cancer cell line HI 299 were particularly sensitive to MCI13E treatment with IC50 values below 3 ?M. Sequential treatment with MCI13E and cisplatin resulted in synergism, suggesting that decreasing RPA's DNA binding activity via a SMI may disrupt RPA's role in cell cycle regulation. Thus, RPA SMIs hold the potential to be used as single agent chemotherapeutics or in combination with current chemotherapeutic regimens to increase their efficacy.Type: GrantFiled: January 16, 2015Date of Patent: September 12, 2017Assignees: Indiana University Research and Technology Corporation, Indiana State UniversityInventors: John J. Turchi, Richard Fitch
-
Publication number: 20150232475Abstract: The invention provides novel nicotinic acetylcholine receptor agonists, for example, phantasmidine and derivatives thereof, for example a compound of formula I. Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acetylcholine receptor agonists.Type: ApplicationFiled: April 24, 2015Publication date: August 20, 2015Applicants: Indiana State University, The United States of America, as Represented by the Secretary, Department of Health and Human ServInventors: Richard W. Fitch, Thomas F. Spande, H. Martin Garraffo, Herman J.C. Yeh, John W. Daly
-
Patent number: 9018227Abstract: The invention provides novel nicotinic acetylcholine receptor agonists, for example, phantasmidine and derivatives thereof, for example a compound of formula (I). Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acetylcholine for agonists.Type: GrantFiled: March 18, 2011Date of Patent: April 28, 2015Assignees: Indiana State University, The United States of America, as Represented by the Secretary, Department of Health and Human ServicesInventors: Richard W. Fitch, Thomas F. Spande, H. Martin Garraffo, Herman J. C. Yeh, Kathryn Daly
-
Patent number: 8088395Abstract: This invention relates to a novel immunoadjuvant, an adjuvant component, and vaccines containing the adjuvant component. The adjuvant includes phytol or a phytol derivative. The adjuvant component, when combined with a soluble or particulate antigen, provides a vaccine with an enhanced ability to induce both humoral and cytotoxic immune responses while displaying reduced toxicity and/or adverse side effects over vaccines that include the antigen but without the benefit of this adjuvant component.Type: GrantFiled: December 6, 2005Date of Patent: January 3, 2012Assignee: Indiana State UniversityInventor: Swapan K. Ghosh
-
Publication number: 20110057389Abstract: A financial board game for use with a targeted population subset, typically including at least one child, is disclosed. The board game includes a board indicating at least one path including a plurality of spaces, wherein each space represents a single playing piece step, wherein each space corresponds to at least one color of a plurality of colors, a plurality of cards, wherein each card specifies at least one financially related question, each of the plurality of cards corresponding to at least one color of the plurality of colors, a plurality of pieces, wherein each pieces represents a player or a plurality of players, each of the plurality of pieces corresponding to at least one color of the plurality of colors, each of the plurality of pieces corresponding to the color of the start position, and a dice or die to generate random criteria for advancing each of the plurality of pieces.Type: ApplicationFiled: September 25, 2008Publication date: March 10, 2011Applicant: Indiana State UniversityInventor: Elizabeth Coit